FDA Investigator Sharon Giamberini
Sharon Giamberini has inspections in 3 countries as of 27 Sep 2023. Sharon Giamberini has collaborated with a combinined 2804 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
141
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Norway,
Poland
Co-Investigator(s):
Aaron F Coleman,
Aaron J Fox,
Abraham M Maekele,
Albert A Salvador,
Alec D Fabus,
Alexander B Anderson,
Alysia C Alger,
Ana Delp Cintron,
Ana P Barido,
Anabel Veiga,
Andrea Dcharles Julien,
Andrew J Mcguffin,
Angela E Glenn,
Angela F Orozco,
Anthony W Lee,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Ashley Gonzalez,
Benita C Okeke,
Betsy C Galliher,
Billy M Battles,
Brant M Schroeder,
Bruce Quijano,
Carla A Norris,
Carlos Hruiz Nunez,
Carol S Davis,
CDR Ileana Barreto Pettit,
CDR Sean T Creighton,
Celia L Hutchinstein,
Charles S Watson,
Christopher T Smith,
Chyla T Hunter,
Cindy Laboy,
Clara E Santiago,
Clausnitzer,
Colleen M Aspinwall,
Courtney A Gilbert,
Craig A Garmendia,
David M Pearson,
David P King,
Delkis J Caycedo,
Dillard H Woody, Jr,
Donald J Mee,
Dorothy P Kramer,
Eduardo Carbonell,
Edward A Fabiano,
Edwards,
Edwin J Gorney,
Emily A Baldwin,
Emily A Green,
Eric R Holm,
Ernest A Clausnitzer,
Ernest L Levins,
Ethan P Stegman,
Frances M Rivera,
Frances M Rivera Rosario,
Gabriel E Muniz,
Gene R Gunn,
Gerard D Difiore,
Gerard Difiore,
Gina C Chen,
Gina Eng,
Giovanna Serpa,
Glenn S Quintanilla,
Haijing Hu,
Harry R Bringger, Jr,
Hector Vallellanes,
Humphrey,
Hunt,
Ivis Lnegron Torres,
Jacqueline E Manjone,
James To Neal,
Jason D Tenney,
Jason P Aun,
Jeffrey G Baravik,
Jennifer A Robinson,
Jennifer Caycedo,
Jennifer L Huntington,
Jennifer Lalama,
Jennifer M Menendez,
Jessica L Pressley,
Joanne E King,
John J Bernal,
Jontae D Sanders,
Joseph P Dudley,
Juan C Gonzalez Rivera,
Karen M Rodriguez,
Karissa J Mccaw,
Karl D Hezel,
Karlton T Watson,
Katherine M Taylor,
Laura M Lopez,
Lenora M Amason,
Leo J Lagrotte,
Leroy Terrelonge,
Leslin M Coachman,
Leyden Guerrero,
Linda K Matheny,
Lisa A Warner,
Lissette Paiz,
Lizaida E Rodriguez,
Lourdes Andujar,
LT Daveta L Bailey,
LT Kimberly M Hull,
LT Prince D Brown,
LT Tamara J Henderson,
Luis A Martinez Larracuente,
Lundy H Patrick,
Luz I Collado,
Marc Balzarini,
Marinee Flores Marrero,
Mary F Bodick,
Matthew B Thomaston,
Megan K Otero,
Melissa J Hill,
Mendoza,
Meredith M Cobb,
Meredith P Soehl, Investigator,
Michael C Lombardi,
Minerva Rogers,
Neimar Lopez Martinez,
Nicole E Knowlton,
Nicole M Bell,
Norton,
Omayra Nrodriguez Ruiz,
Ormond,
Pablo Alcantara,
Pablo Feliciano,
Paul A Licata,
Paul H Dakin,
Rachel A Peters,
Raymond A Lyn, Jr,
Reynolds,
Robert J Goldman,
Rodney W Lenger,
Ronan F King,
Roy R Rinc,
Rozelle G Smith,
Sally Gopaul,
Sandra Carpio,
Saundrea A Munroe,
Sheila P Barthelemy,
Sherbet L Samuels,
Sheri L Stephenson,
Sonia M Monges,
Stacey A Meyer,
Stacey F Allard,
Stacey L Witherwax,
State Agency,
Stephanie C Milan,
Stephanie D Crockett,
Susan M Turcovski,
Teresa I Navas,
Teresa M Hillebrandt,
Timothy A Tennell,
Toby L Keaton,
Tracy L Reed,
Victor Spanioli,
William A Oetting,
Yazmith Guzman
Sharon Giamberini's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2018 | EIR | OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-19 |
| September, 2021 | FDA 483 | Natures Health Options, LLC - Form 483, 2021-09-28 |
| September, 2021 | EIR | Be Powerful, LLC - EIR, 2021-09-07 |
| January, 2018 | FDA 483 Response | OXYGEN DEVELOPMENT, L.L.C. - Form 483R, 2018-02-01 |
| September, 2021 | EIR | Natures Health Options, LLC - EIR, 2021-09-28 |
| September, 2021 | FDA 483 | Be Powerful, LLC - Form 483, 2021-09-07 |
| January, 2018 | FDA 483 | OXYGEN DEVELOPMENT, L.L.C. - Form 483, 2018-01-17 |
| January, 2018 | EIR | OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-17 |
| August, 2016 | FDA 483 | Florida Crystals Food Corporation - Form 483, 2016-08-11 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more